agilon health, inc. (AGL)
NYSE: AGL · Real-Time Price · USD
27.90
+2.58 (10.19%)
Apr 28, 2026, 4:00 PM EDT - Market closed
agilon health Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 463 | 286 | 783 | 5,096 | 6,647 | 10,629 | |
| Market Cap Growth | -80.23% | -63.53% | -84.64% | -23.34% | -37.46% | - | |
| Enterprise Value | 215 | 12 | 434 | 4,583 | 5,743 | 9,604 | |
| Last Close Price | 27.90 | 17.22 | 47.50 | 313.75 | 403.50 | 675.00 | |
| PS Ratio | 0.08 | 0.05 | 0.13 | 1.18 | 2.78 | 6.99 | |
| PB Ratio | 3.65 | 2.25 | 1.66 | 7.71 | 6.39 | 9.74 | |
| P/TBV Ratio | 12.47 | 7.69 | 2.25 | 8.88 | 6.52 | 10.68 | |
| EV/Sales Ratio | 0.04 | 0.00 | 0.07 | 1.06 | 2.40 | 6.31 | |
| Debt / Equity Ratio | 0.29 | 0.29 | 0.09 | 0.07 | 0.05 | 0.06 | |
| Net Debt / Equity Ratio | -1.96 | -1.96 | -0.76 | -0.67 | -0.79 | -0.90 | |
| Net Debt / EBITDA Ratio | 0.61 | 0.61 | 1.33 | 1.99 | 8.74 | 2.75 | |
| Net Debt / FCF Ratio | 2.09 | 2.09 | 5.05 | 2.57 | 5.62 | 6.34 | |
| Asset Turnover | 3.95 | 3.95 | 3.49 | 2.51 | 1.46 | 1.50 | |
| Quick Ratio | 0.92 | 0.92 | 1.24 | 1.48 | 2.56 | 3.74 | |
| Current Ratio | 1.02 | 1.02 | 1.26 | 1.52 | 2.71 | 3.83 | |
| Return on Equity (ROE) | -135.64% | -135.64% | -44.22% | -22.95% | -8.66% | -95.15% | |
| Return on Assets (ROA) | -17.51% | -17.51% | -10.21% | -8.43% | -3.92% | -22.56% | |
| Return on Capital Employed (ROCE) | -216.20% | -216.20% | -48.80% | -30.40% | -8.90% | -29.80% | |
| Earnings Yield | -84.53% | -137.06% | -33.23% | -5.15% | -1.60% | -3.82% | |
| FCF Yield | -25.70% | -41.68% | -9.07% | -3.38% | -2.20% | -1.46% | |
| Buyback Yield / Dilution | -0.73% | -0.73% | -0.50% | -0.19% | -9.45% | -15.29% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.